{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T22:31:11Z","timestamp":1787869871085,"version":"build-2784847793"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:00:00Z","timestamp":1779926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T00:00:00Z","timestamp":1785456000000},"content-version":"vor","delay-in-days":64,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K08-AI171183"],"award-info":[{"award-number":["K08-AI171183"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1R01-AI165671"],"award-info":[{"award-number":["1R01-AI165671"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K23-HL159275"],"award-info":[{"award-number":["K23-HL159275"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The practice of obtaining follow-up blood cultures (FUBCs) in patients with gram-negative bloodstream infections (GN-BSI) remains controversial. The current study had two goals: (1) to internally validate our earlier findings of decreased mortality in patients with FUBCs and increased mortality in those with persistent GN-BSI, and (2) to identify mechanisms by which FUBCs might impact clinical care and outcome.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Adults with GN-BSI at Duke University were enrolled from 2015 to 2021. Cox proportional hazards models with propensity score-weighting were used to examine associations of FUBCs and positive FUBCs with attributable and all-cause in-hospital mortality. Immortal time bias was addressed by treating FUBCs as a time-dependent variable and through sensitivity analyses. To understand the potential impact of FUBCs on clinical care, matched cohorts were generated (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200941 in each group): (1) no FUBCs, (2) FUBCs negative for growth, and (3) FUBCs positive for growth (i.e., persistent GN-BSI). Infection-related consultations, imaging studies, and procedures were determined for each matched cohort.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Of the 1291 patients in this study, FUBCs were obtained in 78% (1012 patients) and positive in 20% (199 patients). After adjusting for immortal time bias, obtaining FUBCs remained associated with decreased attributable mortality (Hazard ratio [HR] 0.39; 95% confidence interval [CI] 0.32\u20130.49;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.0001). Persistent GN-BSI was associated with increased attributable mortality (HR 1.77; 95% CI, 1.24\u20132.52;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.002). Obtaining FUBCs was associated with subsequent infectious diseases (ID) consultation (No FUBCs: 2\/41 [5%]; FUBCs: 21\/82 [26%];\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.0001). This finding was primarily due to patients with persistent GN-BSI (FUBCs negative: 6\/41 [15%]; FUBCs positive: 15\/41 [37%];\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.04). Patients with persistent GN-BSI had a higher rate of source control procedures (FUBCs positive: 12\/41 [29%]; All others: 11\/82 [13%]);\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.05).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Obtaining FUBCs was associated with decreased mortality. This mortality effect could stem from increased ID consults after FUBCs and increased source control procedures following positive FUBCs.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-026-13579-x","type":"journal-article","created":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T16:24:31Z","timestamp":1779985471000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The impact of follow-up blood cultures on mortality and management in patients with gram-negative bloodstream infections: a validation cohort study"],"prefix":"10.1186","volume":"26","author":[{"given":"Joshua T.","family":"Thaden","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felicia","family":"Ruffin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence P.","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parisa","family":"Farahani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Divyam","family":"Goel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua B.","family":"Parsons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Vance G.","family":"Fowler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stacey A.","family":"Maskarinec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,28]]},"reference":[{"key":"13579_CR1","doi-asserted-by":"crossref","unstructured":"Thaden JT, Li Y, Ruffin F, Maskarinec SA, Hill-Rorie JM, Wanda LC, Reed SD, Fowler VG Jr. Increased costs associated with bloodstream infections caused by multidrug-resistant gram-negative bacteria are due primarily to patients with hospital-acquired infections. Antimicrob Agents Chemother. 2017;61(3).","DOI":"10.1128\/AAC.01709-16"},{"issue":"6","key":"13579_CR2","doi-asserted-by":"publisher","first-page":"e1004199","DOI":"10.1371\/journal.pmed.1004199","volume":"20","author":"K Allel","year":"2023","unstructured":"Allel K, Stone J, Undurraga EA, Day L, Moore CE, Lin L, Furuya-Kanamori L, Yakob L. The impact of inpatient bloodstream infections caused by antibiotic-resistant bacteria in low- and middle-income countries: A systematic review and meta-analysis. PLoS Med. 2023;20(6):e1004199.","journal-title":"PLoS Med"},{"issue":"4","key":"13579_CR3","doi-asserted-by":"publisher","first-page":"e0242921","DOI":"10.1128\/jcm.02429-21","volume":"60","author":"M Verway","year":"2022","unstructured":"Verway M, Brown KA, Marchand-Austin A, Diong C, Lee S, Langford B, Schwartz KL, MacFadden DR, Patel SN, Sander B, Johnstone J, Garber G, Daneman N. Prevalence and Mortality Associated with Bloodstream Organisms: a Population-Wide Retrospective Cohort Study. J Clin Microbiol. 2022;60(4):e0242921.","journal-title":"J Clin Microbiol"},{"issue":"6","key":"13579_CR4","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1111\/1469-0691.12195","volume":"19","author":"M Goto","year":"2013","unstructured":"Goto M, Al-Hasan MN. Overall burden of bloodstream infection and nosocomial bloodstream infection in North America and Europe. Clin Microbiol Infect. 2013;19(6):501\u20139.","journal-title":"Clin Microbiol Infect"},{"issue":"7","key":"13579_CR5","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/j.cmi.2020.01.025","volume":"26","author":"SA Maskarinec","year":"2020","unstructured":"Maskarinec SA, Park LP, Ruffin F, Turner NA, Patel N, Eichenberger EM, van Duin D, Lodise T, Fowler VG Jr., Thaden JT. Positive follow-up blood cultures identify high mortality risk among patients with Gram-negative bacteraemia. Clin Microbiol Infect. 2020;26(7):904\u201310.","journal-title":"Clin Microbiol Infect"},{"issue":"9","key":"13579_CR6","doi-asserted-by":"publisher","first-page":"e2232576","DOI":"10.1001\/jamanetworkopen.2022.32576","volume":"5","author":"JT Thaden","year":"2022","unstructured":"Thaden JT, Cantrell S, Dagher M, Tao Y, Ruffin F, Maskarinec SA, Goins S, Sinclair M, Parsons JB, Eichenberger E, Fowler VG Jr. Association of Follow-up Blood Cultures With Mortality in Patients With Gram-Negative Bloodstream Infections: A Systematic Review and Meta-analysis. JAMA Netw Open. 2022;5(9):e2232576.","journal-title":"JAMA Netw Open"},{"issue":"9","key":"13579_CR7","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1016\/j.cmi.2023.02.024","volume":"29","author":"M Gatti","year":"2023","unstructured":"Gatti M, Bonazzetti C, Tazza B, Pascale R, Miani B, Malosso M, Beci G, Marzolla D, Rinaldi M, Viale P, Giannella M. Impact on clinical outcome of follow-up blood cultures and risk factors for persistent bacteraemia in patients with gram-negative bloodstream infections: a systematic review with meta-analysis. Clin Microbiol Infect. 2023;29(9):1150\u20138.","journal-title":"Clin Microbiol Infect"},{"issue":"12","key":"13579_CR8","doi-asserted-by":"publisher","first-page":"ofac568","DOI":"10.1093\/ofid\/ofac568","volume":"9","author":"J Shinohara","year":"2022","unstructured":"Shinohara J, Hanai S, Jung J, Song KH, Iwata M, Terasawa T. Association of Repeated Blood Cultures With Mortality in Adult Patients With Gram-Negative Bacilli Bacteremia: A Systematic Review and Meta-analysis. Open Forum Infect Dis. 2022;9(12):ofac568.","journal-title":"Open Forum Infect Dis"},{"issue":"7","key":"13579_CR9","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/j.cmi.2024.03.025","volume":"30","author":"SWX Ong","year":"2024","unstructured":"Ong SWX, Luo J, Fridman DJ, Lee SM, Johnstone J, Schwartz KL, Diong C, Patel SN, MacFadden D, Langford B, Tong SYC, Brown KA, Daneman N. Follow-up blood cultures do not reduce mortality in hospitalized patients with Gram-negative bloodstream infection: a retrospective population-wide cohort study. Clin Microbiol Infect. 2024;30(7):890\u20138.","journal-title":"Clin Microbiol Infect"},{"issue":"9","key":"13579_CR10","doi-asserted-by":"publisher","first-page":"ofae479","DOI":"10.1093\/ofid\/ofae479","volume":"11","author":"JH Ryder","year":"2024","unstructured":"Ryder JH, Van Schooneveld TC, Diekema DJ, Fabre V. Every Crisis Is an Opportunity: Advancing Blood Culture Stewardship During a Blood Culture Bottle Shortage. Open Forum Infect Dis. 2024;11(9):ofae479.","journal-title":"Open Forum Infect Dis"},{"issue":"9","key":"13579_CR11","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1093\/cid\/ciz535","volume":"70","author":"MN Al-Hasan","year":"2020","unstructured":"Al-Hasan MN, Baddour LM. Resilience of the Pitt Bacteremia Score: 3 Decades and Counting. Clin Infect Dis. 2020;70(9):1834\u20136.","journal-title":"Clin Infect Dis"},{"issue":"11","key":"13579_CR12","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.1093\/cid\/cix648","volume":"65","author":"CN Canzoneri","year":"2017","unstructured":"Canzoneri CN, Akhavan BJ, Tosur Z, Andrade PEA, Aisenberg GM. Follow-up Blood Cultures in Gram-Negative Bacteremia: Are They Needed? Clin Infect Dis. 2017;65(11):1776\u20139.","journal-title":"Clin Infect Dis"},{"issue":"6","key":"13579_CR13","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1093\/cid\/ciae068","volume":"78","author":"PK Ankrah","year":"2024","unstructured":"Ankrah PK, Bock A, Ruffin F, Hanson BM, Arias CA, Maskarinec SA, Parsons J, Fowler VG Jr., Thaden JT. Persistent Gram-negative Bloodstream Infection Increases the Risk of Recurrent Bloodstream Infection With the Same Species. Clin Infect Dis. 2024;78(6):1458\u201361.","journal-title":"Clin Infect Dis"},{"issue":"2","key":"13579_CR14","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1093\/cid\/ciad663","volume":"78","author":"AM Peri","year":"2024","unstructured":"Peri AM, O\u2019Callaghan K, Rafiei N, Graves B, Sinclair H, Brischetto A, Lim K, Parkes-Smith J, Eustace M, Davidson N, Tabah A, Stewart A, Chatfield MD, Harris PNA, Paterson DL. Persistence of Detectable Pathogens by Culture-Independent Systems (T2 Magnetic Resonance) in Patients With Bloodstream Infection: Prognostic Role and Possible Clinical Implications. Clin Infect Dis. 2024;78(2):283\u201391.","journal-title":"Clin Infect Dis"},{"issue":"5","key":"13579_CR15","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1007\/s15010-024-02202-3","volume":"52","author":"U Mondal","year":"2024","unstructured":"Mondal U, Warren E, Bookstaver PB, Kohn J, Al-Hasan MN. Incidence and predictors of complications in Gram-negative bloodstream infection. Infection. 2024;52(5):1725\u201331.","journal-title":"Infection"},{"key":"13579_CR16","doi-asserted-by":"publisher","first-page":"100811","DOI":"10.1016\/j.eclinm.2021.100811","volume":"34","author":"R Amipara","year":"2021","unstructured":"Amipara R, Winders HR, Justo JA, Bookstaver PB, Kohn J, Al-Hasan MN. Impact of follow up blood cultures on outcomes of patients with community-onset gram-negative bloodstream infection. EClinicalMedicine. 2021;34:100811.","journal-title":"EClinicalMedicine"},{"issue":"7","key":"13579_CR17","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1016\/j.cmi.2020.01.023","volume":"26","author":"M Giannella","year":"2020","unstructured":"Giannella M, Pascale R, Pancaldi L, Monari C, Ianniruberto S, Malosso P, Bussini L, Bartoletti M, Tedeschi S, Ambretti S, Lewis R, Viale P. Follow-up blood cultures are associated with improved outcome of patients with gram-negative bloodstream infections: retrospective observational cohort study. Clin Microbiol Infect. 2020;26(7):897\u2013903.","journal-title":"Clin Microbiol Infect"},{"issue":"9","key":"13579_CR18","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1093\/cid\/ciad383","volume":"77","author":"S Shulder","year":"2023","unstructured":"Shulder S, Tamma PD, Fiawoo S, Dzintars K, Escobar D, Livorsi DJ, Malani AN, Palacio D, Spivak ES, Zimmerman M, Bork JT. Infectious Diseases Consultation Associated With Reduced Mortality in Gram-Negative Bacteremia. Clin Infect Dis. 2023;77(9):1234\u20137.","journal-title":"Clin Infect Dis"},{"issue":"4","key":"13579_CR19","first-page":"855","volume":"79","author":"SWX Ong","year":"2024","unstructured":"Ong SWX, Luo J, Fridman DJ, Lee SM, Johnstone J, Schwartz KL, Diong C, Patel SN, MacFadden DR, Langford BJ, Tong SYC, Brown KA, Daneman N. Association Between Infectious Diseases Consultation and Mortality in Hospitalized Patients With Gram-negative Bloodstream Infection: A Retrospective Population-wide Cohort Study. Clin Infect Dis. 2024;79(4):855\u201363.","journal-title":"Clin Infect Dis"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-026-13579-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13579-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13579-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T22:43:29Z","timestamp":1785451409000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-026-13579-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,28]]},"references-count":19,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["13579"],"URL":"https:\/\/doi.org\/10.1186\/s12879-026-13579-x","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,28]]},"assertion":[{"value":"7 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki and approved by the Duke Institutional Review Board (IRB). Written informed consent was obtained from patients or their legal representative.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1408"}}